Immunohistochemical testing of GISTs using CD117 markers: the UK NEQAS ICC & ISH external quality assessment data show significant differences in the performance of methods in regular use - Top-Institutions - MDSpire

Immunohistochemical testing of GISTs using CD117 markers: the UK NEQAS ICC & ISH external quality assessment data show significant differences in the performance of methods in regular use

  • By

  • Andrew Dodson

  • Suzanne Parry

  • July 17, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    UK National External Quality Assessment Scheme for Immunocytochemistry and In-Situ-Hybridisation
    UK National External Quality Assessment Scheme for Immunocytochemistry and In-Situ-Hybridisation

    London, England

    Key Differentiators

    • Pathology

  • #2

    College of American Pathologists
    College of American Pathologists

    Northfield, Illinois

    Key Differentiators

    • Pathology

  • #3

    NordiQC EQA organisation
    NordiQC EQA organisation

    Copenhagen, Denmark

    Key Differentiators

    • Pathology

  • #4

    National University Hospital
    National University Hospital

    Singapore, Singapore

    Key Differentiators

    • Pathology

Original Source(s)

Immunohistochemical testing of GISTs using CD117 markers: the UK NEQAS ICC & ISH external quality assessment data show significant differences in the performance of methods in regular use

  • by Andrew Dodson, Suzanne Parry

  • July 17, 2026

Related Content

Zolbetuximab in the treatment of advanced gastric and gastroesophageal junction cancer: a systematic review

A machine learning-based prognostic model for de novo metastatic HR-positive breast cancer: SEER cohort with external validation

Case Report: Epidemiology, clinical features and progress in disease management for lymphoepithelial carcinoma of salivary glands: report of 3 cases